{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:15:30Z","timestamp":1785546930053,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiovasc Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with end-stage renal disease (ESRD) who are on hemodialysis (HD) have reduced vascular compliance and are likely to develop heart failure (HF). In this study, we estimated the prevalence of HF pre- and post-HD in ESRD using the current guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We prospectively investigated HF in ESRD patients on HD using echocardiography pre- and post-HD. We used the structural and functional abnormality criteria of the 2021 European Society of Cardiology guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 54 patients were enrolled. The mean age was 62.6\u00a0years, and 40.1% were male. Forty-five patients (83.3%) had hypertension, 28 (51.9%) had diabetes, and 20 (37.0%) had ischemic heart disease. The mean N-terminal-pro brain natriuretic peptide BNP (NT-proBNP) level was 12,388.8\u2009\u00b1\u20092,592.2\u00a0pg\/dL. The mean ideal body weight was 59.3\u00a0kg, mean hemodialysis time was 237.4\u00a0min, and mean real filtration was 2.8\u00a0kg. The mean left ventricular ejection fraction (LVEF) was 62.4%, and mean left ventricular end-diastolic diameter was 52.0\u00a0mm in pre-HD. Post-HD echocardiography showed significantly lower left atrial volume index (33.3\u2009\u00b1\u200915.9 vs. 40.6\u2009\u00b1\u200917.1, <jats:italic>p<\/jats:italic>\u2009=\u20090.030), tricuspid regurgitation jet V (2.5\u2009\u00b1\u20090.4 vs. 2.8\u2009\u00b1\u20090.4\u00a0m\/s, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and right ventricular systolic pressure (32.1\u2009\u00b1\u200910.3 vs. 38.4\u2009\u00b1\u200911.6, <jats:italic>p<\/jats:italic>\u2009=\u20090.005) compared with pre-HD. There were no differences in LVEF, E\/E\u2032 ratio, or left ventricular global longitudinal strain. A total of 88.9% of pre-HD patients and 66.7% of post-HD patients had either structural or functional abnormalities in echocardiographic parameters according to recent HF guidelines (<jats:italic>p<\/jats:italic>\u2009=\u20090.007).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our data showed that the majority of patients undergoing hemodialysis satisfy the diagnostic criteria for HF according to current HF guidelines. Pre-HD patients had a 22.2% higher incidence in the prevalence of functional or structural abnormalities as compared with post-HD patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s44348-024-00003-8","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T15:02:07Z","timestamp":1718204527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pre- and post-hemodialysis differences in heart failure diagnosis by current heart failure guidelines in patients with end-stage renal disease"],"prefix":"10.1186","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5435-7449","authenticated-orcid":false,"given":"Bong-Joon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hyun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-8381","authenticated-orcid":false,"given":"Soo-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-2422","authenticated-orcid":false,"given":"Sung-Il","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9528-7494","authenticated-orcid":false,"given":"Hyunsu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6491-2426","authenticated-orcid":false,"given":"Jung-Ho","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3973-4541","authenticated-orcid":false,"given":"Ho Sik","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9595-7355","authenticated-orcid":false,"given":"Ye Na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3657-7082","authenticated-orcid":false,"given":"Yeonsoon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6341-6711","authenticated-orcid":false,"given":"Hark","family":"Rim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1093\/ndt\/gfp104","volume":"24","author":"S Genovesi","year":"2009","unstructured":"Genovesi S, Valsecchi MG, Rossi E, et al. Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrol Dial Transplant. 2009;24:2529\u201336.","journal-title":"Nephrol Dial Transplant"},{"issue":"A7","key":"3_CR2","first-page":"e1","volume":"59","author":"AJ Collins","year":"2012","unstructured":"Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59(A7):e1-420.","journal-title":"Am J Kidney Dis"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/sdi.12878","volume":"33","author":"B Roehm","year":"2020","unstructured":"Roehm B, Gulati G, Weiner DE. Heart failure management in dialysis patients: many treatment options with no clear evidence. Semin Dial. 2020;33:198\u2013208.","journal-title":"Semin Dial"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/ki.1995.22","volume":"47","author":"RN Foley","year":"1995","unstructured":"Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186\u201392.","journal-title":"Kidney Int"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0002-9343(03)00366-8","volume":"115","author":"R Agarwal","year":"2003","unstructured":"Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115:291\u20137.","journal-title":"Am J Med"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1053\/j.ajkd.2014.01.450","volume":"64","author":"DY Chiu","year":"2014","unstructured":"Chiu DY, Green D, Abidin N, Sinha S, Kalra PA. Echocardiography in hemodialysis patients: uses and challenges. Am J Kidney Dis. 2014;64:804\u201316.","journal-title":"Am J Kidney Dis"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1053\/j.jrn.2018.01.015","volume":"28","author":"M Bossola","year":"2018","unstructured":"Bossola M, Pepe G, Vulpio C. The frustrating attempt to limit the interdialytic weight gain in patients on chronic hemodialysis: new insights into an old problem. J Ren Nutr. 2018;28:293\u2013301.","journal-title":"J Ren Nutr"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J"},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","volume":"138","author":"YN Reddy","year":"2018","unstructured":"Reddy YN, Carter RE, Obokata M, Redfield MM, Borlaug BA. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 2018;138:861\u201370.","journal-title":"Circulation"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/ejhf.1741","volume":"22","author":"B Pieske","year":"2020","unstructured":"Pieske B, Tsch\u00f6pe C, de Boer RA, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2020;22:391\u2013412.","journal-title":"Eur J Heart Fail"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1-39.e14.","journal-title":"J Am Soc Echocardiogr"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","volume":"29","author":"SF Nagueh","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29:277\u2013314.","journal-title":"J Am Soc Echocardiogr"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"LG Rudski","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685\u2013713.","journal-title":"J Am Soc Echocardiogr"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.echo.2018.11.011","volume":"32","author":"JJ Silbiger","year":"2019","unstructured":"Silbiger JJ. Pathophysiology and echocardiographic diagnosis of left ventricular diastolic dysfunction. J Am Soc Echocardiogr. 2019;32:216-232.e2.","journal-title":"J Am Soc Echocardiogr"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1093\/eurheartj\/ehx184","volume":"38","author":"BA Borlaug","year":"2017","unstructured":"Borlaug BA, Obokata M. Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease. Eur Heart J. 2017;38:2874\u20138.","journal-title":"Eur Heart J"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.36628\/ijhf.2022.0001","volume":"4","author":"BJ Kim","year":"2022","unstructured":"Kim BJ, Kim SJ, Im SI, et al. Increased right ventricular pressure as a predictor of acute decompensated heart failure in end-stage renal disease patients on maintenance hemodialysis. Int J Heart Fail. 2022;4:154\u201362.","journal-title":"Int J Heart Fail"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.ahj.2008.07.021","volume":"156","author":"DY Leung","year":"2008","unstructured":"Leung DY, Boyd A, Ng AA, Chi C, Thomas L. Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications. Am Heart J. 2008;156:1056\u201364.","journal-title":"Am Heart J"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/echo.15587","volume":"40","author":"AC Peters","year":"2023","unstructured":"Peters AC, Lee J, Jankowski M, Thomas JD. Relationship between left atrial reservoir strain, volumes, and geometry: Insights from simple theoretical model. Echocardiography. 2023;40:592\u20135.","journal-title":"Echocardiography"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/HYPERTENSIONAHA.108.112334","volume":"52","author":"AY Wang","year":"2008","unstructured":"Wang AY, Wang M, Lam CW, Chan IH, Zhang Y, Sanderson JE. Left ventricular filling pressure by Doppler echocardiography in patients with end-stage renal disease. Hypertension. 2008;52:107\u201314.","journal-title":"Hypertension"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.echo.2005.10.006","volume":"19","author":"R Sharma","year":"2006","unstructured":"Sharma R, Pellerin D, Gaze DC, et al. Mitral peak Doppler E-wave to peak mitral annulus velocity ratio is an accurate estimate of left ventricular filling pressure and predicts mortality in end-stage renal disease. J Am Soc Echocardiogr. 2006;19:266\u201373.","journal-title":"J Am Soc Echocardiogr"},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.5414\/CNP71380","volume":"71","author":"M Svensson","year":"2009","unstructured":"Svensson M, Gorst-Rasmussen A, Schmidt EB, Jorgensen KA, Christensen JH. NT-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease. Clin Nephrol. 2009;71:380\u20136.","journal-title":"Clin Nephrol"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jchf.2015.07.014","volume":"3","author":"JA Schaub","year":"2015","unstructured":"Schaub JA, Coca SG, Moledina DG, Gentry M, Testani JM, Parikh CR. Amino-terminal pro-B-type natriuretic peptide for diagnosis and prognosis in patients with renal dysfunction: a systematic review and meta-analysis. JACC Heart Fail. 2015;3:977\u201389.","journal-title":"JACC Heart Fail"}],"container-title":["Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44348-024-00003-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44348-024-00003-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44348-024-00003-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T15:02:27Z","timestamp":1718204547000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcvi.biomedcentral.com\/articles\/10.1186\/s44348-024-00003-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1186\/s44348-024-00003-8","relation":{},"ISSN":["2586-7296"],"issn-type":[{"value":"2586-7296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"assertion":[{"value":"3 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Kosin University Gospel Hospital in Busan, South Korea (No. 2022\u201302-003). Written informed consent was obtained from all enrolled patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no financial conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}